v3.26.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Common stock, shares, beginning balance at Dec. 31, 2024   107,060,000      
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 7,977,577 $ 107 $ 2,898,418 $ 5,263,110 $ (184,058)
Net income 1,007,346     1,007,346  
Other comprehensive (loss) income 29,176       29,176
Common stock issued for share-based compensation, shares   348,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   (100,000)      
Tax withholding related to vesting of restricted stock (15,479) $ 0 (15,479)    
Share-based compensation expense 16,692   16,692    
Common stock, shares, ending balance at Sep. 30, 2025   107,308,000      
Stockholders' equity, ending balance at Sep. 30, 2025 9,015,312 $ 107 2,899,631 6,270,456 (154,882)
Common stock, shares, beginning balance at Jun. 30, 2025   107,247,000      
Stockholders' equity, beginning balance at Jun. 30, 2025 8,546,130 $ 107 2,892,426 5,814,513 (160,916)
Net income 455,943     455,943  
Other comprehensive (loss) income 6,034       6,034
Common stock issued for share-based compensation, shares   61,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   0      
Tax withholding related to vesting of restricted stock (43) $ 0 (43)    
Share-based compensation expense 7,248   7,248    
Common stock, shares, ending balance at Sep. 30, 2025   107,308,000      
Stockholders' equity, ending balance at Sep. 30, 2025 $ 9,015,312 $ 107 2,899,631 6,270,456 (154,882)
Common stock, shares, beginning balance at Dec. 31, 2025 107,309,794 107,310,000      
Stockholders' equity, beginning balance at Dec. 31, 2025 $ 9,537,993 $ 107 2,902,013 6,791,339 (155,466)
Net income 1,340,251     1,340,251  
Other comprehensive (loss) income (19,654)       (19,654)
Common stock issued for share-based compensation, shares   176,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   (5,000)      
Tax withholding related to vesting of restricted stock (945) $ 0 (945)    
Share-based compensation expense $ 23,088   23,088    
Common stock, shares, ending balance at Sep. 30, 2026 107,481,115 107,481,000      
Stockholders' equity, ending balance at Sep. 30, 2026 $ 10,880,733 $ 107 2,924,156 8,131,590 (175,120)
Common stock, shares, beginning balance at Jun. 30, 2026   107,469,000      
Stockholders' equity, beginning balance at Jun. 30, 2026 10,320,338 $ 107 2,915,837 7,560,527 (156,133)
Net income 571,063     571,063  
Other comprehensive (loss) income (18,987)       (18,987)
Common stock issued for share-based compensation, shares   16,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   (4,000)      
Tax withholding related to vesting of restricted stock (751) $ 0 (751)    
Share-based compensation expense $ 9,070   9,070    
Common stock, shares, ending balance at Sep. 30, 2026 107,481,115 107,481,000      
Stockholders' equity, ending balance at Sep. 30, 2026 $ 10,880,733 $ 107 $ 2,924,156 $ 8,131,590 $ (175,120)